RESEARCH. DEVELOP. COLLABORATE. COMMERCIALISE.

BiVictriX was founded in 2017 to exploit a unique and highly novel approach that delivers a step-change in the target selectivity of cancer biotherapeutics. Through targeting cancer-restricted cell surface antigen fingerprints, BiVictriX delivers a...

COBO Technologies is a fast growing start-up company based in Copenhagen, Denmark, that is specialised in products and services for Quality Control of CRISPR modified cells and animals.The proprietary CRISPR InDel Profiling Platform - CIPP, for...

CODA Biotherapeutics is a preclinical stage biotechnology company with a revolutionary chemogenetic platform aimed to control the activity of neurons. With CODA’s chemogenetics platform, target neuronal populations are modified using gene therapy to ...

KidneyCure Ltd. is an Israeli biotechnology company developing a disruptive regenerative cell-therapy approach to treat advanced Chronic Kidney Disease (CKD) patients. The technology was initially developed by Prof. Dekel at the Sheba Medical Center ...

LightOx has developed new therapies for oral tongue cancers. We developed our selective drug candidate by fusing an HDAC inhibitor, to a LightOx molecule to create a new, patented class of drugs. The drug retains efficacy in cancer cell targets and...

Lightricity’s unique photovoltaic technology delivers up to 6x more power per area than other technologies in low light level environments (e.g. inside buildings or train carriages).We enable functionality previously not accessible with light energy ...

 RheinCell Therapeutics GmbH focuses on the GMP-compliant generation of human induced pluripotent stem cells (iPSC) from HLA-homozygous allogeneic umbilical cord blood (CB). The field of cell therapy is one of the most promising developments in...

At Remissio we use AI to design immunotherapy, exciting new cancer treatment that modified you immune cells to fight cancer. This promising therapy is available for less than 1 % of patients because of dangerous side effects damage healthy cells and ...

Cenya Imaging is developing a clinical stage contrast agent to label, track and quantify cell therapies in humans over extended periods of time. Cenya’s BEAds for CONtrast enhancement (BEACONs) offer contrast for 19F-MRI, ultrasound and...

Anjarium Biosciences AG is at the forefront of the emerging field of exosome-based therapeutics, with a focus on advancing its pipeline of targeted RNA medicines for cancer and rare monogenic diseases. Anjarium’s proprietary Hybridosome™ technology...

Atelerix is biotech company based in Newcastle-Upon-Tyne, UK. With seed funding from Innovate UK and other renowned investment firms, we have commercialised the work of Professor Che Connon, head of the Tissue Engineering Department at Newcastle...

A4P has sector leading expertise and proven achievements in global shipping of time and condition critical materials.A4P’s client customised, fully managed and competitively costed solutions involve extensive research into vendor selection, focused...

At NETRI, we design, fabricate and exploit 3D microfluidic chips to reproduce neural circuits. NETRI is a young company-private research institute that aims at understanding the structural and functional mechanistic of neural circuits, neurological...

GenEvolutioN is an expert spin off, dedicated to in vitro genetic toxicology and toxicology expertise using new Human cell models. GenEvolutioN is in line with the evolution of biological and technological progress. The use of stem cells and a whole ...

HAYA Therapeutics is a Switzerland-based pre-clinical stage biopharmaceutical company dedicated to treating heart failure through the discovery and development of targeted first-in-class RNA-based therapeutics, with a specific focus on long...

Wren Healthcare is a UK registered healthcare company, founded by clinical nurse specialists. We work with the NHS, pharmaceutical companies and private healthcare providers to treat patients in their home. Our specialist team of homecare nurses are ...

Ilya Pharma, a clinical stage biopharmaceutical company, develops next-generation biologics to treat wounds in skin and mucosa. 

innoVitro is a service provider with outstanding expertise in the mechanobiology of hiPSC-derviced cardiomyocytes. Our proprietary technology allows for the quantification of cardiac contractility under physiological mechanical conditions in 96...

EVerZom works towards the democratization of regenerative medicine, using biological sub-cellular tools – extracellular vesicles - which are considered as an efficient and safer alternative to cell therapies. EVerZom, a spin off from a CNRS/Paris...

REM Analytics is developing the next generation of microbiome based therapeutics. We developed a unique technology for profiling human microbiomes in a quantitatively and comprehensively with strain level resolution. Using our analytical...

Founded by Dr Mark Kotter, bit bio is an award-winning spinout from the University of Cambridge. By applying an engineering approach to synthetic and stem cell biology, Mark and his team have developed proprietary technologies for the efficient and...

Our mission is to be the reference supplier of top-quality poly(2-oxazoline)s and polyethyleneimines. We strive to offer easy access of novel polymers to the research community and support the development of applications in industry via design and...

CellulaREvolution is a technology driven company that spun-out from Newcastle University. CellulaREvolution was established after the co-founders identified that there was a large market opportunity in the fields of biologics, cellular therapies and ...

denovoMATRIX is focused on the design and manufacture of biomimetic yet fully chemically defined coatings for the culture of stem cells.

EvoBiotech is developing an innovative, highly effective, low-cost, easy-to-handle dressing to heal chronic wound, based on a new active substance, derived from plants, which directly promote wound healing and regeneration of skin and blood vessel.